Fig. 6: Increased secondary BA and angiocrine factors post LDLT in human subjects.

BA analysis in human donors of LDLT (a, b). PLSDA and heatmap displaying clear segregation of BA profile at different time-points. Relative abundance (log normalized) for BA showing significant differences at different time-points. c LCA (d) TDCA (e) TUDCA (f) TCA. Concentration of angiocrine factors as determined by ELISA. g Wnt2 (h) HGF in LSEC-CM was checked using ELISA. Data are expressed as mean ± SD (n = 3 each for BA profiling, for ELISA n = 6, **p < 0.001, ***p < 0.0001).